ClinVar Miner

Submissions for variant NM_000231.3(SGCG):c.347G>A (p.Arg116His) (rs17314986)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 13
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
EGL Genetic Diagnostics, Eurofins Clinical Diagnostics RCV000078405 SCV000110251 benign not specified 2015-10-26 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000078405 SCV000269824 benign not specified 2014-11-26 criteria provided, single submitter clinical testing p.Arg116His in exon 4 of SGCG: This variant is not expected to have clinical sig nificance because it has been identified in 14% (1198/8600) of European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu /EVS/; dbSNP rs17314986).
PreventionGenetics,PreventionGenetics RCV000078405 SCV000303091 benign not specified criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV001094097 SCV000383248 benign Sarcoglycanopathy 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Illumina Clinical Services Laboratory,Illumina RCV000325049 SCV000383249 likely benign Limb-Girdle Muscular Dystrophy, Recessive 2016-06-14 criteria provided, single submitter clinical testing
GeneDx RCV000078405 SCV000519755 benign not specified 2016-01-07 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Athena Diagnostics Inc RCV000078405 SCV000677486 benign not specified 2021-04-23 criteria provided, single submitter clinical testing
SIB Swiss Institute of Bioinformatics RCV000270116 SCV000803541 benign Severe autosomal recessive muscular dystrophy of childhood - North African type 2018-05-31 criteria provided, single submitter curation This variant is interpreted as a Benign - Stand Alone, for Muscular dystrophy, limb-girdle, type 2C, in Autosomal Recessive manner. The following ACMG Tag(s) were applied: BA1 => Allele frequency is >5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium.
ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories RCV000270116 SCV001156905 benign Severe autosomal recessive muscular dystrophy of childhood - North African type 2020-08-24 criteria provided, single submitter clinical testing
Invitae RCV000270116 SCV001728098 benign Severe autosomal recessive muscular dystrophy of childhood - North African type 2020-12-05 criteria provided, single submitter clinical testing
Pars Genome Lab RCV000270116 SCV001750003 benign Severe autosomal recessive muscular dystrophy of childhood - North African type 2021-07-01 criteria provided, single submitter clinical testing
Genetic Services Laboratory, University of Chicago RCV000078405 SCV000152726 likely benign not specified no assertion criteria provided clinical testing Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.
Natera, Inc. RCV000270116 SCV001455348 benign Severe autosomal recessive muscular dystrophy of childhood - North African type 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.